22 Feb 10 Elite Pharmaceuticals, Inc. 3rd Quarter 2010 Financial Results (GlobeNewswire via Yahoo! Finance)

NORTHVALE, N.J. — Elite Pharmaceuticals, Inc. announced results for the third quarter ended December 31, 2009. Revenues for the three months ended December 31, 2009 were $917,383, an increase of $680,603 or approximately 287% over revenues for the comparable period of the prior year, and consisted of $744,948 in manufacturing fees and $172,435 in royalty fees.